Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV2 COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04743011
What this trial is testing

Enriched Heparin Anti COVID-19 Trial

Who this might be right for
Covid19
UPECLIN HC FM Botucatu Unesp 27
Testing effectiveness (Phase 2)Study completedNCT04400929
What this trial is testing

Using GM-CSF as a Host Directed Therapeutic Against COVID-19

Who this might be right for
COVIDSars-CoV2ARDS, Human
Singapore General Hospital 2
Large-scale testing (Phase 3)Study completedNCT04356937
What this trial is testing

Efficacy of Tocilizumab on Patients With COVID-19

Who this might be right for
SARS-CoV 2
Massachusetts General Hospital 243
Not applicableStudy completedNCT06517745
What this trial is testing

Effect of Prone Positionning in Non Intubated Patients

Who this might be right for
SARS-CoV 2 PneumoniaAcute Respiratory Distress SyndromeProne Positioning
Mongi Slim Hospital 114
Not applicableUnknownNCT05118711
What this trial is testing

Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms

Who this might be right for
Patients Post-COVID-19Controls
Arno Schmidt-Trucksäss 128
Large-scale testing (Phase 3)Temporarily pausedNCT04252664
What this trial is testing

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV-2
Capital Medical University 308
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableStudy completedNCT04307563
What this trial is testing

Effects of Mindfulness Training on Burnout and Mood in Hospital Employees

Who this might be right for
Anxiety DepressionBurnout
Stanford University 52
Early research (Phase 1)Study completedNCT07518771
What this trial is testing

PA-001 Ph.1 Study in Healthy and Elderly Subjects

Who this might be right for
COVID - 19
PeptiDream Inc. 47
Not applicableStudy completedNCT04339634
What this trial is testing

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

Who this might be right for
COVIDDrug EffectDrug Interaction+1 more
Tabula Rasa HealthCare 12,873
Testing effectiveness (Phase 2)Ended earlyNCT04954014
What this trial is testing

Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients

Who this might be right for
ARDS, HumanCoronavirus Infection
Maimónides Biomedical Research Institute of Córdoba 21
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Not applicableStudy completedNCT04469634
What this trial is testing

Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?

Who this might be right for
SARS-CoV2COVID-19
Institute of Tropical Medicine, Belgium 150
Large-scale testing (Phase 3)Study completedNCT05543616
What this trial is testing

Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

Who this might be right for
SARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19
BioNTech SE 4,338
Not applicableStudy completedNCT04452604
What this trial is testing

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

Who this might be right for
Acute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaSARS-CoV-2
French Innovative Leukemia Organisation 79
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Not applicableStudy completedNCT04516928
What this trial is testing

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel

Who this might be right for
SARS-CoV InfectionCovid19
Direction Centrale du Service de Santé des Armées 392
Not applicableStudy completedNCT05338736
What this trial is testing

Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 Patients

Who this might be right for
SARS CoV 2 InfectionCOVID-19
University Magna Graecia 45
Large-scale testing (Phase 3)Study completedNCT04497987
What this trial is testing

LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff

Who this might be right for
COVID-19SARS-CoV2
Eli Lilly and Company 1,180
Testing effectiveness (Phase 2)WithdrawnNCT05118763
What this trial is testing

Intranasal INNA-051 for Prevention of COVID-19 in Adults

Who this might be right for
COVID-19 Pandemic
ENA Respiratory Pty Ltd
Next Page